Cromwell Holdings LLC acquired a new stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) during the 3rd quarter, HoldingsChannel reports. The firm acquired 1,616 shares of the medical instruments supplier’s stock, valued at approximately $62,000.
A number of other hedge funds have also recently bought and sold shares of BAX. First PREMIER Bank bought a new position in shares of Baxter International during the third quarter valued at about $25,000. Innealta Capital LLC bought a new stake in Baxter International in the 2nd quarter worth about $27,000. LRI Investments LLC bought a new position in shares of Baxter International during the 1st quarter worth approximately $39,000. Versant Capital Management Inc boosted its stake in shares of Baxter International by 974.2% in the 2nd quarter. Versant Capital Management Inc now owns 1,332 shares of the medical instruments supplier’s stock worth $45,000 after buying an additional 1,208 shares during the last quarter. Finally, Archer Investment Corp boosted its stake in shares of Baxter International by 20.8% in the 2nd quarter. Archer Investment Corp now owns 2,235 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 385 shares during the last quarter. 90.19% of the stock is owned by hedge funds and other institutional investors.
Baxter International Stock Down 2.1 %
BAX opened at $35.97 on Friday. The company has a 50 day moving average of $37.68 and a 200 day moving average of $36.50. The company has a current ratio of 1.40, a quick ratio of 0.91 and a debt-to-equity ratio of 1.35. Baxter International Inc. has a 12 month low of $31.75 and a 12 month high of $44.01. The company has a market cap of $18.33 billion, a PE ratio of 6.92, a price-to-earnings-growth ratio of 1.28 and a beta of 0.59.
Analyst Upgrades and Downgrades
BAX has been the topic of a number of recent analyst reports. Evercore ISI dropped their price target on Baxter International from $46.00 to $45.00 and set an “outperform” rating on the stock in a report on Tuesday, July 2nd. Citigroup boosted their price target on shares of Baxter International from $38.00 to $40.00 and gave the stock a “neutral” rating in a report on Tuesday, October 1st. Morgan Stanley downgraded shares of Baxter International from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $39.00 to $30.00 in a report on Monday, July 15th. Wells Fargo & Company dropped their target price on shares of Baxter International from $44.00 to $40.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Baxter International from $44.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $41.20.
Get Our Latest Report on Baxter International
Baxter International Profile
Baxter International Inc, through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories.
Recommended Stories
- Five stocks we like better than Baxter International
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- Dividend Capture Strategy: What You Need to Know
- MarketBeat Week in Review – 10/21- 10/25
- Where to Find Earnings Call Transcripts
- Texas Roadhouse Stock Steering for New Highs This Year
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.